[1]
2026. Quality-of-Life Outcomes Among Patients Achieving High-Threshold Facial or Total Body Repigmentation With Ruxolitinib Cream in Nonsegmental Vitiligo. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s753. DOI:https://doi.org/10.25251/r559dc08.